QuantumScape (QS) Stock Rockets on Solid-State Battery Breakthrough – Analysts Split on Future
23 October 2025
5 mins read

QuantumScape (QS) Stock Rockets on Solid-State Battery Breakthrough – Analysts Split on Future

  • 2025 Stock Rally: QS shares have surged roughly 170–180% year-to-date, far outpacing the market ts2.tech. The stock hit near $19 in early October as investors cheered progress on its solid-state batteries 1 .
  • Q3 Earnings Beat: In Q3 (ended Sept 30), QuantumScape reported a net loss of $105.8M (–$0.18/share), slightly better than the –$0.20 consensus ts2.tech. It also recorded $12.8M in “customer billings” – the first invoices to partners – and ended the quarter with about $1.08B in cash ts2.tech (extending its cash runway into 2030) 2 .
  • Milestone Achievements: The company has begun shipping its new Cobra-processed “B1” solid-state battery samples, powering VW/PowerCo’s Ducati V21L e-motorcycle prototype (achieving ~844 Wh/L energy density and 10→80% in ~12 minutes) benzinga.com ts2.tech. It also struck key partnerships with Corning and Murata to scale its ceramic separators ts2.tech au.investing.com – moves analysts called a “major vote of confidence” in QuantumScape’s tech 3 .
  • Volatile Stock Action: QS is extremely volatile (beta ~4). On Oct 22 it briefly plunged ~12–13% intraday (to ~$13.5) as traders sold into the rally, then jumped ~10% after hours when the strong results and B1 news were released ts2.tech au.investing.com. Even after swings, the stock remains ~150% above January levels 4 .
  • Mixed Analyst Views: Wall Street remains skeptical. Most analysts rate QS a Hold/Sell with 12-month targets around $5–$6 (implying >50% downside) ts2.tech. For example, Baird recently raised its target to $11 ts2.tech, while Weiss Ratings still has a “Sell (D‑)” call marketbeat.com. Conversely, some bullish models peg QS’s fair value much higher – one Simply Wall St. analysis notes a “fair value near ~$25” given its tech lead 5 .
  • Investor Sentiment: Retail traders have embraced QS’s high-risk profile, but institutions are active too – Vanguard and UBS boosted stakes in 2025 ts2.tech. At the same time, company insiders have sold into the rally (about 2.3M shares, ~$27M last quarter) ts2.tech marketbeat.com, underscoring the stock’s speculative nature.
  • Outlook and Forecasts: Wall Street expects losses to narrow gradually (FY2025 EPS est. ~–$0.78 247wallst.com) as QuantumScape ramps towards commercialization. However, future value is hotly debated. Analysts’ price targets range wildly (roughly $2.50 to $16 investing.com), reflecting uncertainty. Bulls argue the recent technical breakthroughs and partnerships aren’t fully priced in ts2.tech, while skeptics caution that QS must prove it can scale manufacturing before justifying its ~$9B market cap ts2.tech 6 .

QuantumScape Corporation (NYSE: QS), the Silicon Valley developer of solid-state lithium-metal batteries, has been in the spotlight this week amid a flurry of news. The company’s long-anticipated Q3 2025 results (released Oct 22 after the close) narrowed losses and delivered key operational wins. QS reported a GAAP net loss of $105.8 million (–$0.18 per share) for Q3 – slightly better than analysts’ –$0.20 estimate ts2.tech. More notably, it reported $12.8 million in “customer billings” (invoices issued to partners) for the quarter ts2.tech. Management says this metric – a proxy for future revenue – signals growing commercial engagement; CFO Kevin Hettrich explained that these were “the total value of all invoices issued by QS to our customers and partners” and are “evidence of our capital-light model at work” benzinga.com. QuantumScape ended Sept 2025 with roughly $1.08 billion in cash ts2.tech, extending its runway into the 2030s benzinga.com through recent stock offerings.

These financial results were accompanied by major technical and partnership milestones. In September, QS completed baseline production of its new “Cobra” separator process, and in Q3 it shipped its first Cobra-processed QSE-5 “B1” sample cells ts2.tech ts2.tech. These cells are part of the VW/Audi/PowerCo launch program – for example, a Ducati V21L electric race bike (PowerCo and Ducati collaboration) ran on QSE-5 cells, achieving about 844 Wh/L and charging 10%→80% in ~12 minutes ts2.tech ts2.tech. CEO Siva Sivaram noted that shipping the B1 samples was “another critical step toward achieving our goal of revolutionizing energy storage” ts2.tech. On the partnerships front, QuantumScape recently signed deals with Corning Inc. (jointly developing its ceramic separator manufacturing) and expanded collaboration with Murata Manufacturing (second phase of ceramics co-production) benzinga.com benzinga.com. TechStock² (ts2.tech) reports analysts viewed the Corning partnership as “a major vote of confidence” in QS’s technology ts2.tech, since Corning brings decades of glass/ceramics expertise. Together with Murata (a precision-ceramics leader), these deals form a supply-chain “ecosystem” that QS says is key to scaling its battery production benzinga.com 7 .

Despite the operational buzz, the market’s reaction has been bumpy. In recent days QS stock has swung wildly. After peaking near $16–$19 in late Sept/early Oct (around 170–180% YTD gains ts2.tech ts2.tech), QS shares pulled back just before earnings. On Oct 21 the stock dipped back into the mid-$15s ts2.tech. On Oct 22 it plunged roughly 12–13% intraday (as low as ~$13.5) amid profit-taking and jitters ahead of the report ts2.tech ts2.tech. However, after QS beat expectations and announced the B1 shipments, the stock rebounded sharply – jumping about 10% in after-hours trading ts2.tech 247wallst.com. As one market analyst summarized, “QuantumScape delivered a constructive print – narrowing losses and achieving a critical commercialization milestone… The 10% stock surge reflects investor enthusiasm” 247wallst.com. (Even after this volatility, QS remains roughly 150% above its January price ts2.tech, highlighting the year’s roller-coaster ride.)

Expert Commentary: Analysts are deeply divided. The average Wall Street 12-month price target is very low (around $5–6 ts2.tech), reflecting caution. For example, Weiss Ratings reiterated a “sell (D–)” rating heading into earnings marketbeat.com. By contrast, some observers emphasize the upside potential of the technology: a Simply Wall St. model pegs fair value near $25 based on QS’s lead in solid-state batteries ts2.tech. Robert W. Baird recently raised its QS price target from $6 to $11 (still below today’s levels) ts2.tech. In post-earnings coverage, analysts noted that the improved guidance (adj. EBITDA loss now $245–$260M) and the new “customer billings” metric lend credibility to QS’s capital-light licensing model investing.com 247wallst.com. However, skepticism remains: firms remind investors that QS is still pre-revenue on a GAAP basis, and its ~$9 billion market cap is based entirely on future promise ts2.tech ainvest.com. One analysis warns that “near-term execution risks – such as production delays or competitive advancements – could pressure the stock,” even if the long-term fair-value thesis ($25) “remains intact” 6 .

Medium/Long-Term Outlook: Looking ahead, forecasts are wide-ranging. Most agree QS must now prove its ability to scale. Management believes the company is moving toward pilot-scale production on its “Eagle Line” and eventual licensing deals. Analysts’ consensus sees losses shrinking (Street EPS forecasts ~–$0.78 for FY2025 247wallst.com and –$0.74 for FY2026) as some revenue (licensing, partnerships) begins. But price targets vary from the low single-digits up to the high teens (InvestingPro notes a range ~$2.50–$16 investing.com). In public comments, CEO Sivaram stressed that QS’s goals are now being met, saying “our vision for commercialization… is beginning to take shape” benzinga.com. CFO Hettrich similarly highlighted that hitting the first $12.8M in billings is “proof that our capital-light model” is working, with near-term cash inflows and long-term royalties to come benzinga.com. If QuantumScape can keep executing (and if solid-state EV demand remains strong), many technologists see room for far higher valuation. But most prudent analysts warn that the stock’s high valuations hinge on achieving these milestones – and given QS’s history of delays, volatility is likely to persist.

Sources: Recent financial news and market analysis from TechStock² (ts2.tech) ts2.tech ts2.tech, Benzinga ts2.tech benzinga.com, Investing.com investing.com au.investing.com, MarketBeat marketbeat.com, TipRanks tipranks.com tipranks.com, and 24/7 Wall St. 247wallst.com 247wallst.com, among others. All data are as of Oct. 23, 2025.

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Evolution Gaming’s Stock Tanks After Q3 Miss and Rival Smear Allegations
Previous Story

Evolution Gaming’s Stock Tanks After Q3 Miss and Rival Smear Allegations

Crypto Crash or Comeback? Yueda Digital (YDKG) Stock Crashes 90% After Fundraise, Then Bounces – What’s Next
Next Story

Crypto Crash or Comeback? Yueda Digital (YDKG) Stock Crashes 90% After Fundraise, Then Bounces – What’s Next

Go toTop